COM:IMMIXBIO
Immix Biopharma, Inc.
- Stock
Last Close
1.68
22/11 21:00
Market Cap
53.89M
Beta: -
Volume Today
249.22K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|
average inventory | ||||||
average payables | 249.94K - | 197.64K 20.93% | 708.12K 258.28% | 1.35M 91.09% | ||
average receivables | 151.59K - | 76.58K 49.48% | 140.71K 83.75% | 713.94K 407.37% | ||
book value per share | -0.43 - | -0.54 24.82% | 4.90 1,008.62% | 0.95 80.65% | 0.95 0.17% | |
capex per share | -0.00 - | -0.00 - | -0.00 - | |||
capex to depreciation | -0.32 - | -9.53 - | ||||
capex to operating cash flow | 0.01 - | 0.00 - | 0.00 - | |||
capex to revenue | ||||||
cash per share | 0.09 - | 0.04 48.74% | 4.80 10,679.57% | 0.97 79.86% | 1.01 4.36% | |
days of inventory on hand | ||||||
days payables outstanding | 95.66K - | |||||
days sales outstanding | -1.04 - | |||||
debt to assets | 4.35 - | 7.60 74.75% | 0.00 99.96% | |||
debt to equity | -1.12 - | -0.87 22.92% | 0.00 100.32% | |||
dividend yield | ||||||
earnings yield | -0.03 - | -0.04 13.53% | -1.86 5,132.31% | -0.26 86.12% | -0.13 50.32% | |
enterprise value | 34.35M - | 35.91M 4.55% | -4.52M 112.59% | 18.37M 506.31% | 102.49M 458.07% | |
enterprise value over ebitda | -40.84 - | -79.63 94.99% | 3.35 104.21% | -2.24 166.73% | -6.35 184.21% | |
ev to operating cash flow | -43.48 - | -88.74 104.10% | 2.84 103.20% | -2.48 187.17% | -9.01 263.57% | |
ev to sales | -0.21 - | |||||
free cash flow per share | -0.09 - | -0.05 51.17% | -0.43 838.78% | -0.53 23.21% | -0.66 23.49% | |
free cash flow yield | -0.03 - | -0.01 51.17% | -0.12 867.79% | -0.23 91.54% | -0.10 59.14% | |
graham net net | -0.44 - | -0.55 23.60% | 4.75 972.18% | 0.86 82.01% | 0.85 1.13% | |
graham number | 1.06 - | 1.26 19.04% | 27.05 2,047.48% | 3.55 86.86% | 4.35 22.42% | |
income quality | 0.81 - | 0.35 56.59% | 0.07 81.51% | 0.90 1,281.11% | 0.74 18.11% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | |
interest coverage | -7.66 - | -4.45 41.90% | -7.52 68.91% | -16.54K 219,886.66% | ||
interest debt per share | 0.50 - | 0.48 3.97% | 0.06 86.93% | 0.00 99.94% | ||
inventory turnover | ||||||
invested capital | -1.12 - | -0.87 22.92% | 0.00 100.32% | |||
market cap | 30.98M - | 32.20M 3.94% | 13.07M 59.40% | 31.80M 143.24% | 120.00M 277.34% | |
net current asset value | -3.66M - | -4.74M 29.59% | 17.98M 479.58% | 13.15M 26.88% | 16.07M 22.18% | |
net debt to ebitda | -4.00 - | -8.22 105.51% | 13.04 258.54% | 1.64 87.46% | 1.09 33.64% | |
net income per share | -0.12 - | -0.13 13.53% | -6.64 4,975.49% | -0.59 91.07% | -0.89 50.11% | |
operating cash flow per share | -0.09 - | -0.05 50.71% | -0.43 838.31% | -0.53 23.27% | -0.66 22.92% | |
payables turnover | 0.00 - | |||||
receivables turnover | -350.08 - | |||||
research and ddevelopement to revenue | -0.05 - | |||||
return on tangible assets | -1.03 - | -2.13 106.19% | -1.34 36.99% | -0.55 58.81% | -0.77 40.25% | |
revenue per share | -6.45 - | |||||
roe | 0.27 - | 0.24 9.05% | -1.36 658.59% | -0.63 53.86% | -0.94 50.36% | |
roic | -1.90 - | 0.73 138.52% | -0.07 110.26% | -0.63 734.18% | -0.99 57.60% | |
sales general and administrative to revenue | -0.04 - | |||||
shareholders equity per share | -0.43 - | -0.54 24.82% | 4.90 1,008.62% | 0.95 80.65% | 0.95 0.17% | |
stock based compensation to revenue | -0.01 - | |||||
tangible asset value | -3.65M - | -4.73M 29.73% | 17.99M 480.29% | 13.16M 26.85% | 16.20M 23.13% | |
tangible book value per share | -0.43 - | -0.54 24.82% | 4.90 1,008.62% | 0.95 80.65% | 0.93 1.40% | |
working capital | -3.66M - | -4.74M 29.59% | 17.98M 479.58% | 13.62M 24.24% | 16.07M 17.92% |
All numbers in (except ratios and percentages)